MYRANDA SPIGLER: Open Payments
NPI 1225715121 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,507 in 86 payments from 12 companies in 2025. Trend: 2023 $624 · 2024 $2,561 · 2025 $6,507
Speaker / faculty: $4,250Food & beverage: $2,002Travel & lodging: $144Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $4,694 |
| Teva Pharmaceuticals USA, Inc. | 15 | $765 |
| Neurocrine BioSciences, Inc. | 14 | $281 |
| Alkermes, Inc. | 13 | $256 |
| Axsome Therapeutics, Inc. | 4 | $159 |
| Otsuka America Pharmaceutical, Inc. | 6 | $151 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Corium, LLC | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $33 |
Products named: VRAYLAR, UZEDY, INGREZZA, ARISTADA, AUSTEDO XR, REXULTI, Auvelity, FANAPT.
Industry payments across MD — which companies pay providers there.
